£43k
−13%vs Mar 2024Active11016274Private limited companySalisbury
PROTEOME LIMITED
Significant control: Edward Mark Clayson (25–50%), Christine Anne Clayson (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Proteome Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
PROTEOME LIMITED is an active private limited company (company number 11016274) incorporated on 17 October 2017, registered in Salisbury. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 March 2025, showing net assets of £43k, with 2 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 13% on the prior period (£49k).
Peer position · net assets
By net assets it sits in the upper half of 278 comparable companies in Other (median £129, upper quartile £59k).
02
Ownership and control
- Dr Edward Mark Clayson
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Mrs Christine Anne Clayson
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Mrs Christine Anne Clayson
- has significant influence or control
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 17 October 20179 yrs ago
- Next accounts due
- 31 December 2026in 69 days
- Confirmation statement due
- 31 October 2026in 8 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
2
No changevs Mar 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | £43k | — | — | — | — | — | 2 |
| 31 March 2024 | £49k | — | — | — | — | — | 2 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets above zeroNet assets £42,885 at 31 March 2025
- Incorporated five or more years agoIncorporated 17 October 2017
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 69 days
- Confirmation statement duein 8 days
- Accounts period endNet assets £43k · micro accounts
- Accounts period endNet assets £49k · micro accounts
- Incorporated
08
Similar companies in the UK
- BETA BUGS LIMITEDTring · inc. Oct 2017
- CLINICAL TRIALS CONSULTANCY (CTS) LIMITEDNorwich · inc. Sept 2017
- THE INTERNATIONAL STEM CELL BANKING INITIATIVE (ISCBI) LIMITEDIlfracombe · inc. Aug 2017
- BILITECH LTDKington · inc. Dec 2017
- SANDJAW LTDRoss-On-Wye · inc. Jul 2017
- GLYCERIN & GENERATOR PRODUCTION COMPANY LIMITEDPeterborough · inc. Jul 2017
All companies incorporated on 17 October 2017 · in Oct 2017.
09
Reminders for PROTEOME LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.